Stock Rich List
#4944 on the rich list of 14,644 insiders

Michael H. Davidson

Chief Executive Officer at NewAmsterdam Pharma Company; Director at Silence Therapeutics; Director at Lisata Therapeutics.

$21.3M
in disclosed stock, −$249K (−1.16%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
4944th of 14,644
Companies held
4
Largest holding
NAMS, 98.7% of total
Latest SEC filing
Sep 14, 2026

What the $21.3M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
NewAmsterdam Pharma Company NAMS
Ordinary Shares
Directly792,923$19.51$15.5M72.6%Form 4, Sep 14, 2026
NewAmsterdam Pharma Company NAMS
Ordinary Shares
Through Michael H. Davidson 2026 Grantor Retained Annuity Trust285,715$19.51$5.6M26.1%Form 4, Sep 14, 2026
Silence Therapeutics SLN
Ordinary Shares
Directly12,993$19.81$257K1.2%Form 3, Jan 2, 2025
Lisata Therapeutics LSTA
Common Stock
Directly13,984
split-adjusted
$0.91$13K0.1%Form 4, Jan 10, 2022
Tenax Therapeutics TENX
Common Stock
Directly2,881$1.39$4K0.0%Form 4, Jan 9, 2026

Share counts are the amounts Michael H. Davidson reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Sep 14, 2026BoughtNAMS10,000$22.65$227KView
Mar 2, 2026SoldNAMS443,707$33.25$14.8MView
Feb 26, 2026SoldNAMS165,408$33.63$5.6MView
Feb 26, 2026SoldNAMS17,924$34.44$617KView
Feb 25, 2026SoldNAMS46,517$35.11$1.6MView
Feb 25, 2026SoldNAMS10,436$35.96$375KView
Feb 25, 2026SoldNAMS1,300$36.68$48KView
Feb 24, 2026SoldNAMS61,547$36.13$2.2MView
Feb 24, 2026SoldNAMS3,161$36.46$115KView
Jan 7, 2026SoldNAMS11,582——View

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
4941Jesse C. Crawford
Director, Crawford &. Peachtree Corners, GA
$21.3M−$436K (−2.01%)
4942Aurelien Pierre Leon Nolf
Chief Financial Officer, Navan. Palo Alto, CA
$21.3M−$570K (−2.60%)
4943Daniel R. Needham
Executive Vice President, Nucor. Charlotte, NC
$21.3M−$258K (−1.19%)
4944Michael H. Davidson
Chief Executive Officer, NewAmsterdam Pharma Company
$21.3M−$249K (−1.16%)
4945Christopher A. O.'Herlihy
President & CEO, Illinois Tool Works. Glenview, IL
$21.3M−$412K (−1.90%)
4946Michael A. Pizzi
Head Technology & Operations, Morgan Stanley. New York, NY
$21.3M−$754K (−3.42%)
4947Lisa Sanfilippo
Director, John B. Sanfilippo & Son. Elgin, IL
$21.3M−$154K (−0.72%)

Other NewAmsterdam Pharma Company insiders

All NAMS insiders

Questions

How much stock does Michael H. Davidson own?

Michael H. Davidson holds $21,318,348 in listed stock based on SEC filings and current prices, mostly NewAmsterdam Pharma Company (NAMS). That ranks 4944th on the Stock Rich List.

Is this Michael H. Davidson's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Michael H. Davidson last buy or sell stock?

The most recent open-market trade on file is a purchase of 10,000 NAMS shares on Sep 14, 2026 at $22.65.